• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重α1-抗胰蛋白酶缺乏症(PiZZ型)成人患者的肝胆疾病风险:慢性乙型或丙型病毒性肝炎是否为肝硬化和肝细胞癌的额外风险因素?

Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?

作者信息

Elzouki A N, Eriksson S

机构信息

Department of Medicine, Lund University, University Hospital, Malmö, Sweden.

出版信息

Eur J Gastroenterol Hepatol. 1996 Oct;8(10):989-94. doi: 10.1097/00042737-199610000-00010.

DOI:10.1097/00042737-199610000-00010
PMID:8930564
Abstract

OBJECTIVES

To assess homozygous alpha 1-antitrypsin deficiency (PiZZ) as a risk factor for cirrhosis, hepatocellular carcinoma (HCC) and gallstone disease, and to analyse the respective interrelation-ships and those suggested to exist between PiZZ, alpha 1-antitrypsin and chronic hepatitis B and C.

DESIGN/METHODS: This study was based on 31 autopsied adults with severe alpha 1-antitrypsin deficiency diagnosed during the period 1963-94, in the city of Malmö, Sweden. For each autopsied PiZZ individual, four age- and sex-matched controls were selected from the same autopsy register. The autopsy rate during the study period was 57.2% of all deaths in the city and 85% of deaths at the hospital. Relative risks were estimated in terms of Mantel-Haenszel odds ratios (ORmh).

RESULTS

In the PiZZ group, we found 13 cases of cirrhosis (ORmh = 8.3; 95% CI, 3.8-18.3; P < 0.0001), 5 cases of HCC (ORmh = 5.0; 95% CI, 1.6-15.8; P = 0.008), and 8 cases of gallstone disease (ORmh = 1.0; 95% CI, 0.4-2.3; P = 0.924), compared with 7, 4 and 29 cases, respectively, in the control group. Stratification of the data by age and sex showed the difference in relative risk of cirrhosis between the PiZZ and control groups to be significant in both sexes, but that of HCC to be significant only in the male subgroup. There was no correlation between PiZZ state and gallstone disease in either sex. All PiZZ patients with cirrhosis and HCC had had negative tests for anti-hepatitis B core antigen and/or hepatitis B surface antigen. Of the homozygotes with cirrhosis or HCC for whom frozen sera were available (54% (7/13) and 60% (3/5), respectively), none had antihepatitis C antibodies, as tested both with ELISA-2 and RIBA-3. The prevalence of cirrhosis was higher in the PiZZ group than in controls for all ages above 50 years (P < 0.05). The occurrence of gallstone disease increased steadily with age in the two populations.

CONCLUSIONS

Although males and females with severe alpha 1-antitrypsin deficiency are not at significantly greater risk of gallstone disease, they are at greater risk of cirrhosis and HCC, the risk of HCC being more manifest in males. The risk of cirrhosis or HCC was unrelated to the presence of hepatitis B or C infection.

摘要

目的

评估纯合子α1 -抗胰蛋白酶缺乏症(PiZZ)作为肝硬化、肝细胞癌(HCC)和胆结石疾病的危险因素,并分析PiZZ、α1 -抗胰蛋白酶与慢性乙型和丙型肝炎之间各自的相互关系以及可能存在的关系。

设计/方法:本研究基于1963年至1994年期间在瑞典马尔默市确诊的31例严重α1 -抗胰蛋白酶缺乏症的成年尸检病例。对于每例PiZZ尸检个体,从同一尸检登记册中选取四名年龄和性别匹配的对照。研究期间的尸检率为该市所有死亡人数的57.2%,医院死亡人数的85%。相对风险通过Mantel - Haenszel优势比(ORmh)进行估计。

结果

在PiZZ组中,我们发现13例肝硬化(ORmh = 8.3;95%可信区间,3.8 - 18.3;P < 0.0001),5例HCC(ORmh = 5.0;95%可信区间,1.6 - 15.8;P = 0.008),以及8例胆结石疾病(ORmh = 1.0;95%可信区间,0.4 - 2.3;P = 0.924),而对照组分别为7例、4例和29例。按年龄和性别对数据进行分层显示,PiZZ组和对照组之间肝硬化的相对风险差异在两性中均显著,但HCC的相对风险差异仅在男性亚组中显著。在任何性别中,PiZZ状态与胆结石疾病均无相关性。所有患有肝硬化和HCC的PiZZ患者抗乙型肝炎核心抗原和/或乙型肝炎表面抗原检测均为阴性。对于有肝硬化或HCC且有冷冻血清可用的纯合子(分别为54%(7/13)和60%(3/5)),用ELISA - 2和RIBA - 3检测均未发现抗丙型肝炎抗体。50岁以上各年龄段的PiZZ组肝硬化患病率均高于对照组(P < 0.05)。在两个人群中,胆结石疾病的发生率均随年龄稳步上升。

结论

虽然严重α1 -抗胰蛋白酶缺乏症的男性和女性患胆结石疾病的风险没有显著增加,但他们患肝硬化和HCC的风险更高,HCC的风险在男性中更明显。肝硬化或HCC的风险与乙型或丙型肝炎感染的存在无关。

相似文献

1
Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?严重α1-抗胰蛋白酶缺乏症(PiZZ型)成人患者的肝胆疾病风险:慢性乙型或丙型病毒性肝炎是否为肝硬化和肝细胞癌的额外风险因素?
Eur J Gastroenterol Hepatol. 1996 Oct;8(10):989-94. doi: 10.1097/00042737-199610000-00010.
2
Abdominal aortic aneurysms and alpha 1-antitrypsin deficiency.
J Intern Med. 1994 Nov;236(5):587-91. doi: 10.1111/j.1365-2796.1994.tb00850.x.
3
Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.肝细胞癌的流行病学。对乙型和丙型肝炎低流行地区的病毒及其他风险因素的评估。
Z Gastroenterol. 1994 Mar;32(3):146-51.
4
Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症患者中肝细胞癌的患病率。
J Hepatol. 1994 Dec;21(6):1006-11. doi: 10.1016/s0168-8278(05)80609-9.
5
Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症患者患肝硬化和原发性肝癌的风险。
N Engl J Med. 1986 Mar 20;314(12):736-9. doi: 10.1056/NEJM198603203141202.
6
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.中国河南地区乙型和丙型肝炎病毒感染作为肝细胞癌危险因素的病例对照研究。
Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574.
7
Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.肯尼亚的乙型肝炎病毒、肝细胞癌和肝硬化
East Afr Med J. 1993 Apr;70(4 Suppl):34-6.
8
Hepatitis C virus infection in chronic liver disease in Natal.纳塔尔慢性肝病中的丙型肝炎病毒感染
S Afr Med J. 1996 Jan;86(1):80-3.
9
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.乙型肝炎核心抗体阳性与非酒精性脂肪性肝病患者的肝硬化和肝细胞癌相关。
Am J Gastroenterol. 2020 Jun;115(6):867-875. doi: 10.14309/ajg.0000000000000588.
10
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.

引用本文的文献

1
Insights in Molecular Therapies for Hepatocellular Carcinoma.肝细胞癌分子疗法的见解
Cancers (Basel). 2024 May 10;16(10):1831. doi: 10.3390/cancers16101831.
2
A stacking ensemble machine learning model to predict alpha-1 antitrypsin deficiency-associated liver disease clinical outcomes based on UK Biobank data.基于英国生物库数据的叠加集成机器学习模型预测 α-1 抗胰蛋白酶缺乏症相关肝病临床结局。
Sci Rep. 2022 Oct 11;12(1):17001. doi: 10.1038/s41598-022-21389-9.
3
Liver transplantation for rare liver diseases and rare indications for liver transplant.
罕见肝脏疾病的肝移植及肝移植的罕见适应证
Transl Gastroenterol Hepatol. 2021 Apr 5;6:27. doi: 10.21037/tgh-19-282. eCollection 2021.
4
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification.肝细胞癌(HCC):流行病学、病因学和分子分类。
Adv Cancer Res. 2021;149:1-61. doi: 10.1016/bs.acr.2020.10.001. Epub 2020 Nov 28.
5
The Alpha-1 Antitrypsin Polymer Load Correlates With Hepatocyte Senescence, Fibrosis Stage and Liver-Related Mortality.α1抗胰蛋白酶聚合物负荷与肝细胞衰老、纤维化阶段及肝脏相关死亡率相关。
Chronic Obstr Pulm Dis. 2020 Jul;7(3):151-162. doi: 10.15326/jcopdf.7.3.2019.0158.
6
Update in global trends and aetiology of hepatocellular carcinoma.肝细胞癌全球趋势与病因学的最新进展
Contemp Oncol (Pozn). 2018;22(3):141-150. doi: 10.5114/wo.2018.78941. Epub 2018 Sep 30.
7
Pediatric hepatocellular carcinoma.小儿肝细胞癌。
World J Gastroenterol. 2018 Sep 21;24(35):3980-3999. doi: 10.3748/wjg.v24.i35.3980.
8
Roles of p53 in extrinsic factor-induced liver carcinogenesis.p53在外源性因素诱导的肝癌发生中的作用。
Hepatoma Res. 2017;3:95-104. doi: 10.20517/2394-5079.2017.07. Epub 2017 Jun 6.
9
The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer.基础肝病的诊断与治疗对原发性肝癌预后的作用
Cancer Control. 2017 Jul-Sep;24(3):1073274817729240. doi: 10.1177/1073274817729240.
10
Liver tumors in children with metabolic disorders.代谢紊乱儿童的肝脏肿瘤。
Transl Pediatr. 2015 Oct;4(4):290-303. doi: 10.3978/j.issn.2224-4336.2015.10.08.